Literature DB >> 23417969

Curcumin, a potential therapeutic candidate for retinal diseases.

Lei-Lei Wang1, Yue Sun, Kun Huang, Ling Zheng.   

Abstract

Curcumin, the major extraction of turmeric, has been widely used in many countries for centuries both as a spice and as a medicine. In the last decade, researchers have found the beneficial effects of curcumin on multiple disorders are due to its antioxidative, anti-inflammatory, and antiproliferative properties, as well as its novel function as an inhibitor of histone aectyltransferases. In this review, we summarize the recent progress made on studying the beneficial effects of curcumin on multiple retinal diseases, including diabetic retinopathy, glaucoma, and age-related macular degeneration. Recent clinical trials on the effectiveness of phosphatidylcholine formulated curcumin in treating eye diseases have also shown promising results, making curcumin a potent therapeutic drug candidate for inflammatory and degenerative retinal and eye diseases.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Anti-inflammation; Antioxidative; Curcumin; Epigenetics; Retinal diseases

Mesh:

Substances:

Year:  2013        PMID: 23417969     DOI: 10.1002/mnfr.201200718

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  21 in total

Review 1.  Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.

Authors:  Amir Abbas Momtazi; Giuseppe Derosa; Pamela Maffioli; Maciej Banach; Amirhossein Sahebkar
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

2.  Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders.

Authors:  Aiguo Wu; Emily E Noble; Ethika Tyagi; Zhe Ying; Yumei Zhuang; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta       Date:  2014-12-27

Review 3.  Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss.

Authors:  Yashodhara Sharma; Sandeep Saxena; Arvind Mishra; Anita Saxena; Shankar Madhav Natu
Journal:  Eur J Nutr       Date:  2017-03-03       Impact factor: 5.614

4.  Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca²⁺/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats.

Authors:  Jun Li; Peipei Wang; Yanxia Zhu; Zhen Chen; Tianyan Shi; Wensheng Lei; Songping Yu
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-24       Impact factor: 2.671

Review 5.  One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.

Authors:  Vivek Gupta; Veer B Gupta; Nitin Chitranshi; Sumudu Gangoda; Roshana Vander Wall; Mojdeh Abbasi; Mojtaba Golzan; Yogita Dheer; Tejal Shah; Alberto Avolio; Roger Chung; Ralph Martins; Stuart Graham
Journal:  Cell Mol Life Sci       Date:  2016-06-22       Impact factor: 9.261

Review 6.  Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.

Authors:  Yousef H Aldebasi; Salah M Aly; Arshad H Rahmani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-12-15

Review 7.  Anti-inflammatory role of curcumin in retinal disorders (Review).

Authors:  Federica Franzone; Marcella Nebbioso; Tiziano Pergolizzi; Giuseppe Attanasio; Angela Musacchio; Antonio Greco; Paolo Giuseppe Limoli; Marco Artico; Demetrios A Spandidos; Samanta Taurone; Enzo Agostinelli
Journal:  Exp Ther Med       Date:  2021-05-21       Impact factor: 2.447

Review 8.  Histone Acetyltransferases and Stem Cell Identity.

Authors:  Ruicen He; Arthur Dantas; Karl Riabowol
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

9.  Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study.

Authors:  Fabio Mazzolani; Stefano Togni
Journal:  Clin Ophthalmol       Date:  2013-05-22

10.  Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model.

Authors:  Su Kang Kim; Hosik Seok; Hae Jeong Park; Hye Sook Jeon; Sang Wook Kang; Byung-Cheol Lee; Jooil Yi; Sang Yeol Song; Sang Hyub Lee; Young Ock Kim; Joo-Ho Chung
Journal:  BMC Complement Altern Med       Date:  2015-10-22       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.